State CA
Clinical Trials in California
Recruiting clinical trials with at least one study location in California. Data updated daily from ClinicalTrials.gov.
Top Conditions in California
Frequently Asked Questions — Clinical Trials in California
How many clinical trials are currently recruiting in California?
ClinicalMetric currently tracks 833 actively recruiting clinical trials with at least one location in California. The total number of registered studies—including active but not currently enrolling trials—is 833. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in California?
California hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout California serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in California?
To join a clinical trial in California, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in California maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in California
NCT06150196 N/A
Recruiting
Brain Health & Wellness Classes for Veterans With Traumatic Brain Injury
Condition
Brain Injury Traumatic Mild
Enrollment
80 pts
Location
United States
Sponsor
East Bay Institute for Researc
NCT05005403 Phase 1
Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With N...
Condition
Non-Small Cell Lung Cancer
Enrollment
694 pts
Location
United States, Canada, Israel
Sponsor
AbbVie
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
200 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT05365529 N/A
Recruiting
Time-Restricted Eating for Type II Diabetes: TRE-T2D
Condition
Diabetes Mellitus, Type 2
Enrollment
60 pts
Location
United States
Sponsor
University of California, San
NCT05410977 N/A
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neopl...
Condition
Colorectal Carcinoma
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT05298605 N/A
Recruiting
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Scree...
Condition
Breast Cancer Female
Enrollment
320 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
NCT04191551 N/A
Recruiting
The GAstric Precancerous Conditions Study
Condition
Gastric Cancer
Enrollment
600 pts
Location
United States
Sponsor
Stanford University
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT07359846 Phase 3
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With...
Condition
Severe Asthma
Enrollment
786 pts
Location
United States
Sponsor
Generate Biomedicines
NCT07019922 Phase 3
Recruiting
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Saf...
Condition
Epileptic Encephalopathy
Enrollment
50 pts
Location
United States, Brazil
Sponsor
Praxis Precision Medicines
NCT06185959 N/A
Recruiting
Evaluating a New Mental Health Group for Asians and Asian Americans
Condition
Mental Health Issue
Enrollment
30 pts
Location
United States
Sponsor
Stanford University
NCT03964480 N/A
Recruiting
Prospective Observational International Registry of Patients With Newly Diagnose...
Condition
Peripheral T-Cell Lymphoma
Enrollment
1,000 pts
Location
United States, Italy, Romania
Sponsor
Associazione Angela Serra per
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
792 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT06880341 N/A
Recruiting
Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease
Condition
Moya Moya Disease
Enrollment
88 pts
Location
United States
Sponsor
Stanford University
NCT05800405 EARLY_Phase 1
Recruiting
Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Trea...
Condition
Recurrent Diffuse Large B-Cell Lymphoma
Enrollment
9 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06377969 N/A
Recruiting
Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord St...
Condition
Chronic Pelvic Pain Syndrome
Enrollment
10 pts
Location
United States
Sponsor
Stanford University
Page 1 of 34 — 833 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology